Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature

Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature

Abstract Several studies have demonstrated increased pericardial effusion during anti‐PD‐1 immunotherapy, and treatment in patients who have developed pericardial tamponade is controversial. In this study, we describe a 63‐year‐old woman with stage IVA lung adenocarcinoma given pembrolizumab as a fi...

Full description

Bibliographic Details
Main Authors: Kazuaki Harada, Makoto Ogasawara, Akane Shido, Akimitsu Meno, Soichiro Oda, Shota Yoshida, Sonoe Yoshida, Ayumu Yoshikawa, Ko Ebata, Satoshi Abiko, Naoki Kawagishi, Itsuki Sano, Hisashi Oda, Takuto Miyagishima
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Thoracic Cancer
Subjects:
Immune checkpoint inhibitor
pembrolizumab
pericardial effusion
pericardial tamponade
Online Access:https://doi.org/10.1111/1759-7714.13399

Internet

https://doi.org/10.1111/1759-7714.13399

Similar Items